Study: MPR better for predicting death risk

06/29/2011 | MolecularImaging.net

Myocardial perfusion reserve is a more effective indicator of cardiac death risk than left ventricular ejection fraction and viability range in patients with ischemic heart disease who underwent a PET-driven procedure, according to a study published in the Journal of Nuclear Medicine. "The advantage of PET is that on top of viability, absolute myocardial perfusion can be measured. In addition, MPR can be assessed using vasodilator substances," the Dutch-led researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA